» Articles » PMID: 34694961

Biotherapeutic Effect of Cell-penetrating Peptides Against Microbial Agents: a Review

Overview
Journal Tissue Barriers
Date 2021 Oct 25
PMID 34694961
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Selective permeability of biological membranes represents a significant barrier to the delivery of therapeutic substances into both microorganisms and mammalian cells, restricting the access of drugs into intracellular pathogens. Cell-penetrating peptides usually 5-30 amino acids with the characteristic ability to penetrate biological membranes have emerged as promising antimicrobial agents for treating infections as well as an effective delivery modality for biological conjugates such as nucleic acids, drugs, vaccines, nanoparticles, and therapeutic antibodies. However, several factors such as antimicrobial resistance and poor drug delivery of the existing medications justify the urgent need for developing a new class of antimicrobials. Herein, we review cell-penetrating peptides (CPPs) used to treat microbial infections. Although these peptides are biologically active for infections, effective transduction into membranes and cargo transport, serum stability, and half-life must be improved for optimum functions and development of next-generation antimicrobial agents.

Citing Articles

Conjugated therapeutic proteins as a treatment for bacteria which trigger cancer development.

Halawa M, Newman P, Aderibigbe T, Carabetta V iScience. 2024; 27(10):111029.

PMID: 39635133 PMC: 11615139. DOI: 10.1016/j.isci.2024.111029.


Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders.

Wu Y, Angelova A Nanomaterials (Basel). 2023; 13(23).

PMID: 38063700 PMC: 10708303. DOI: 10.3390/nano13233004.


Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease.

Robledo S, Perez-Silanes S, Fernandez-Rubio C, Poveda A, Monzote L, Gonzalez V Pathogens. 2023; 12(7).

PMID: 37513786 PMC: 10383258. DOI: 10.3390/pathogens12070939.


Antiviral Peptide-Based Conjugates: State of the Art and Future Perspectives.

Todorovski T, Kalafatovic D, Andreu D Pharmaceutics. 2023; 15(2).

PMID: 36839679 PMC: 9958607. DOI: 10.3390/pharmaceutics15020357.

References
1.
Fadzen C, Holden R, Wolfe J, Choo Z, Schissel C, Yao M . Chimeras of Cell-Penetrating Peptides Demonstrate Synergistic Improvement in Antisense Efficacy. Biochemistry. 2019; 58(38):3980-3989. DOI: 10.1021/acs.biochem.9b00413. View

2.
Vives E, Brodin P, Lebleu B . A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 1997; 272(25):16010-7. DOI: 10.1074/jbc.272.25.16010. View

3.
Reddi S, Kumar N, Vij R, Mada S, Kapila S, Kapila R . Akt drives buffalo casein-derived novel peptide-mediated osteoblast differentiation. J Nutr Biochem. 2016; 38:134-144. DOI: 10.1016/j.jnutbio.2016.08.003. View

4.
Gomarasca M, Martins T, Greune L, Hardwidge P, Schmidt M, Ruter C . Bacterium-Derived Cell-Penetrating Peptides Deliver Gentamicin To Kill Intracellular Pathogens. Antimicrob Agents Chemother. 2017; 61(4). PMC: 5365713. DOI: 10.1128/AAC.02545-16. View

5.
Shen W, RYSER H . Poly (L-lysine) and poly (D-lysine) conjugates of methotrexate: different inhibitory effect on drug resistant cells. Mol Pharmacol. 1979; 16(2):614-22. View